Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Elcora Announces Filing of Annual and Interim Financial Statements
-
Toll Brothers Announces Final Opportunity to Purchase in Westshore Community in Cumming, Georgia
-
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
-
Toll Brothers Announces Final Opportunities in Van Wyck Mews Community in Fishkill, New York
-
United States Antimony Corporation to Present at the 2024 ThinkEquity Conference
-
License for 10,000 tonnes of sterile salmon in Ísafjarðardjúp has been revoked
-
Mercado Libre | New Podcast Episode Sheds Light on Ambitious Growth Plans and Strategic Focus Across Latin America
-
Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
-
2024 United States Mint Limited Edition Silver Proof Set™ Available on November 5
-
Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards
-
Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards
-
A Coming Of Age Story That Blends Love, Loss, and Cross-Country Travel
-
Global business travelers embrace train travel as a preferred mode of transport
-
Brunswick Corporation Named One of the ‘World’s Top Companies for Women 2024’ by Forbes
-
El Pollo Loco Unveils Iconic New Restaurant Design and Eyes Significant Expansion as the Brand Approaches 50th Anniversary
-
Alpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 Million
-
End of Day Message
-
Correction: Norsk Hydro: Strong upstream results, building downstream robustness
-
Integrated Power Services (IPS) Announces Partnership with DOD SkillBridge Program
-
BroadRange Logistics Partners with Cascadia Managing Brands to Expand Food and Beverage Warehousing and 3PL Services
-
Anthem Successfully Closes on First Real Estate Development Trust IPO on a Canadian Asset
-
IDB and IDB Invest Approve Over $2 Billion for Biodiversity in 2023
-
Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report
-
Geekvape and Geekbar Shine at Vapouround Awards 2024, Securing Six Prestigious Wins in total and Reinforcing their Global Leaderships
-
Festi hf.: Settlement negotiations with the Icelandic Competition Authority
-
Publishing of Eimskip's third quarter 2024 results
-
Federal Home Loan Bank of Indianapolis Announces Third Quarter 2024 Dividends, Reports Earnings
-
CPABC: BC Labour market has cooled significantly since April 2024
-
Change in the composition of the Board of Directors
-
Lincoln Educational Services Corporation Schedules Third Quarter Earnings Release and Conference Call
-
Alliance Witan PLC - Transaction In Own Shares
-
Lynch Carpenter Investigates Claims in ATSG Data Breach
-
C&F Financial Corporation Announces Net Income for Third Quarter and First Nine Months
-
Suzy Names Grady Leno as New Chief Product & Technology Officer
-
Suzy Names Grady Leno as New Chief Product & Technology Officer
-
Avio USA and ACMI Properties Partner to Design a New Solid Rocket Motor Production Facility in the United States
-
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
14-Year-Old Rare Brain Disease Survivor Publishes First In A Series Of Adventure Middle-Grade Novels After Relearning How To Read And Write
-
McPhy: First-Half Year 2024 Results Growth in Electrolyzer Revenue
-
ASM announces third quarter 2024 results
-
Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD
-
Rocktown Adventures Celebrates 10 Years of Outdoor Adventure with 10th Anniversary Weekend Event
-
Dairy Council of California Releases 2023–2024 Annual Report
-
Ipsos: Monthly declaration of shares and voting rights - September 2024
-
Success of the Public Tender Offer for the capital of Unieuro, Final Results
-
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
-
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
-
Empowering ACSA Members to Tackle Industry Challenges and Build Safety and Business Excellence
-
YES Communities Rejuvenates Long-Time Stonegate Resident's Home
-
Aedifica NV/SA: Interim financial report – Q3 2024
